Profile
Kathryn Rudie Harrigan served as an Independent Director at Cambrex Corp.
from 1994 to 2019.
She was also a Member of the Governors Board at Ronin Development Corp.
Additionally, she worked as a Professor at Columbia Business School.
Prior to her career, she earned an undergraduate degree from Macalester College, an MBA from The University of Texas at Austin, and a doctorate from Harvard University.
Former positions of Kathryn Rudie Harrigan
| Companies | Position | End |
|---|---|---|
| CAMBREX CORPORATION | Director/Board Member | 2019-12-03 |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
| Ronin Development Corp. | Director/Board Member | - |
| Columbia Business School | Corporate Officer/Principal | - |
Training of Kathryn Rudie Harrigan
| Harvard University | Doctorate Degree |
| The University of Texas at Austin | Masters Business Admin |
| Macalester College | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
| Ronin Development Corp. |
- Stock Market
- Insiders
- Kathryn Rudie Harrigan
